Trial Profile
A Phase III Single Arm Trial of PTS (Para toluenesulfonamide Injection) via Bronchoscopy Intervention Intratumoral Injection in Patients with Central Air Way NSCLC Tumor Severe Obstruction
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 Aug 2023
Price :
$35
*
At a glance
- Drugs P-toluenesulfonamide (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 10 Dec 2012 New trial record